List of SBIR/STTR awards granted to Origen Therapeutics
Origen TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Origen Therapeutics from the U.S. Department of Health & Human Services. | SBIR | 2R44GM064261-02 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Origen Therapeutics for $1,840,634.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM064261-02 | Phase II | 1,840,634 | ||||||||
A SBIR Phase II contract was awarded to Origen Therapeutics for $1,578,780.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM070158-02 | Phase II | 1,578,780 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $163,854.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD047995-01 | Phase I | 163,854 | ||||||||
A SBIR Phase II contract was awarded to Origen Therapeutics for $1,223,871.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM064096-02 | Phase II | 1,223,871 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $114,657.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM073306-01 | Phase I | 114,657 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $341,665.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI058402-01 | Phase I | 341,665 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $114,172.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD047062-01 | Phase I | 114,172 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics from the U.S. Department of Health & Human Services. | SBIR | 2R44GM064096-02 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Origen Therapeutics for $1,320,720.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM073306-02 | Phase II | 1,320,720 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI051746-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics from the U.S. Department of Health & Human Services. | SBIR | 2R44HD039583-02 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Origen Therapeutics for $750,002.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HD039583-02 | Phase II | 750,002 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM070158-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $80,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2002-33610-11818 | Phase I | 80,000 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 100,000 | |||||||||
A SBIR Phase II contract was awarded to Origen Therapeutics for $296,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2003-33610-13933 | Phase II | 296,000 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics from the U.S. Department of Agriculture. | SBIR | 2003-33610-13933 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $75,095.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 75,095 | |||||||||
A SBIR Phase I contract was awarded to Origen Therapeutics for $100,023.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 100,023 |
